Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bismuth toxicity--a reassessment.

B Bradley1, M Singleton, A Lin Wan Po

  • 1Pharmacy Practice Research Group, School of Pharmacy, Belfast, Northern Ireland.

Journal of Clinical Pharmacy and Therapeutics
|December 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Altitude-induced central sleep apnea does not affect mean sleep oxygen saturation in young healthy males.

Journal of applied physiology (Bethesda, Md. : 1985)·2025
Same author

Growing pains: Maturity associated variation in injury risk in academy football.

European journal of sport science·2019
Same author

Use of multiple data sources to identify specific drugs and other factors associated with drug and alcohol screening of fatally injured motor vehicle drivers.

Accident; analysis and prevention·2018
Same author

Surveillance of traffic incident management-related occupational fatalities in Kentucky, 2005-2016.

Traffic injury prevention·2018
Same author

Discharge on the day of surgery following unicompartmental knee arthroplasty within the United Kingdom NHS.

The bone & joint journal·2017
Same author

Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability.

Molecular psychiatry·2017
Same journal

Impact of pharmacist-initiated educational interventions on improving medication reconciliation practice in geriatric inpatients during hospital admission in Vietnam.

Journal of clinical pharmacy and therapeutics·2022
Same journal

Evaluation of off-label anti-vascular endothelial growth factor and steroid implant medication uses in macular edema due to retinal vein occlusion in Turkey.

Journal of clinical pharmacy and therapeutics·2022
Same journal

A descriptive analysis of pharmacological management of aggression and/or agitation in patients with traumatic brain injury in a Southwest Virginia inpatient population.

Journal of clinical pharmacy and therapeutics·2022
Same journal

Effects of caregiver counselling on medication persistence and adherence in patients with dementia at a pharmacist-managed clinic: A pilot study.

Journal of clinical pharmacy and therapeutics·2022
Same journal

The 50% and 95% effective doses of remimazolam tosilate with adjuvant sufentanil for sedation in patients with liver cirrhosis undergoing oesophagogastric varices screening endoscopy.

Journal of clinical pharmacy and therapeutics·2022
Same journal

Tumour necrosis factor inhibitor combined with intravenous immunoglobulin and heparin for treatment of recurrent spontaneous abortion: A two-centre, retrospective, cohort study.

Journal of clinical pharmacy and therapeutics·2022
See all related articles

Bismuth compounds like bismuth subsalicylate and colloidal bismuth subcitrate are promoted for diarrhea and ulcers. Historical adverse reactions, including salicylism with bismuth subsalicylate, necessitate careful evaluation of these bismuth therapies.

Area of Science:

  • Pharmacology and Therapeutics
  • Gastroenterology

Background:

  • Bismuth compounds, specifically bismuth subsalicylate and colloidal bismuth subcitrate, are increasingly recommended for treating diarrhea and peptic ulcer disease.
  • Historically, the therapeutic application of bismuth compounds has been associated with significant adverse events.
  • Salicylism is a recognized potential adverse reaction linked to the use of bismuth subsalicylate.

Purpose of the Study:

  • To review the existing literature concerning adverse reactions associated with bismuth compounds.
  • To provide a comprehensive background for assessing the therapeutic value of bismuth subcitrate and bismuth subsalicylate.

Main Methods:

  • Literature review of reported adverse reactions to bismuth compounds.
  • Analysis of historical data on bismuth compound usage and associated side effects.

Related Experiment Videos

Main Results:

  • Identified historical episodes of serious adverse reactions linked to bismuth compounds.
  • Highlighted salicylism as a specific risk associated with bismuth subsalicylate.

Conclusions:

  • A thorough understanding of past adverse reactions is crucial for evaluating current bismuth therapies.
  • The safety profile of bismuth subcitrate and bismuth subsalicylate requires careful consideration in clinical practice.